Search

Displaying results 4961 - 4970 of 10000 in total
  1. Drug

    Ciglitazone

    go.drugbank.com/drugs/DB09201
    Experimental

    Ciglitazone is a potent and selective PPARγ ligand with an EC50 of 3.0 µM. It is also an anti-hyperglycemic agent in the ob/ob murine model in vivo. … Ciglitazone was never used as a medication, but it sparked interest in the effects of thiazolidinediones.

  2. Drug

    Avexitide

    go.drugbank.com/drugs/DB14806
    ApprovedInvestigationalWithdrawn

    Avexitide is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).

  3. Drug

    Parsaclisib

    go.drugbank.com/drugs/DB14867
    Investigational

    Parsaclisib is under investigation in clinical trial NCT03126019 (An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)).

  4. Drug

    Narazaciclib

    go.drugbank.com/drugs/DB19038
    Investigational

    Narazaciclib is under investigation in clinical trial NCT06351644 (On 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed And/or Refractory Multiple Myeloma).

  5. Drug

    Montmorillonite

    go.drugbank.com/drugs/DB13654
    Investigational

    Categories: Compounds used in a research, industrial, or household settingProducts: SmectaGo 3g Oral Suspension In Sachet, IMPIDEM® POLVO PARA RECONSTITUIR A SOLUCION ORAL
  6. Drug

    Metildigoxin

    go.drugbank.com/drugs/DB13401
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Sodium apolate

    go.drugbank.com/drugs/DB13477
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    Betadex

    go.drugbank.com/drugs/DB03995
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Fominoben

    go.drugbank.com/drugs/DB08968
    ApprovedWithdrawn

    Fominoben is an antitussive agent.

  10. Drug

    Azetukalner

    go.drugbank.com/drugs/DB21551
    Investigational

    Azetukalner is under investigation in clinical trial NCT05718817 (An Open-label Study of XEN1101 in Epilepsy). Azetukalner has a monoisotopic molecular weight of 368.23 Da. … Azetukalner is a small molecule drug. The usage of the INN stem '-kalner' in the name indicates that Azetukalner is a opener of calcium-activated (maxi-K) K+-channel.